Skin infections caused by drug-resistant staph on rise
August 16, 2006
A once-rare drug-resistant germ now appears to cause more than half of all skin
infections treated in U.S. emergency rooms, say researchers who documented the
super bug's startling spread in the general population.
Many victims mistakenly thought they just had spider bites that wouldn't
heal, not drug-resistant staph bacteria. Only a decade ago, these germs were
hardly ever seen outside of hospitals and nursing homes.
Doctors also were caught off-guard – most of them unwittingly prescribed
medicines that do not work against the bacteria.
“It is time for physicians to realize just how prevalent this is,” said Dr.
Gregory Moran of Olive View-UCLA Medical Center, who led the study.
Skin infections can be life-threatening if bacteria get into the bloodstream.
Drug-resistant strains can also cause a vicious type of pneumonia and even
“flesh-eating” wounds.
The Centers for Disease Control and Prevention paid for the study, published
in today's New England Journal of Medicine. Several authors have
consulted for companies that make antibiotics.
Researchers analyzed all skin infections among adults who went to hospital
emergency rooms in 11 U.S. cities in August 2004. Of the 422 cases, 249, or
59 percent, were caused by methicillin-resistant Staphylococcus aureus,
or MRSA. Such bacteria are impervious to the penicillin family of drugs long
used for treatment.
The proportion of infections due to MRSA ranged from 15 percent to as high as
74 percent in some hospitals.
The germ typically thrives in health care settings where people have open
wounds and tubes. But in recent years, outbreaks have occurred among prisoners,
children and athletes, with the germ spreading through skin contact or shared
items such as towels. Dozens of people in Ohio, Kentucky and Vermont recently
got MRSA skin infections from tattoos.
The good news: MRSA infections contracted outside a hospital are easier to
treat. The study found that several antibiotics work against them, including
some sulfa drugs that have been around for decades. A separate study in the
journal reports the effectiveness of Cubicin, an antibiotic recently approved to
treat bloodstream infections and heart inflammation caused by MRSA.
However, doctors need to test skin infections to see what germ is causing
them, and to treat each one as if it were MRSA until test results prove
otherwise, researchers said.
Associated Press
Send this page to your friends..